IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity
about
Immunosuppressive networks in the tumour environment and their therapeutic relevanceOver-expression of nicotinamide phosphoribosyltransferase in ovarian cancers.Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.T(H)17 cells in tumour immunity and immunotherapy.Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring.Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.Dendritic cells and tumor microenvironment: a dangerous liaisonAtractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitroThe inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Positive and negative influences of regulatory T cells on tumour immunity.Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.Ovarian cancer stem cells: still an elusive entity?Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.Ovarian carcinoma cells effectively inhibit differentiation and maturation of dendritic cells derived from hematopoietic progenitor cells in vitro.Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients.
P2860
Q29619244-D53BC818-91C1-4D1D-BBDE-BE9B5BD99B9CQ33962022-9D334EA4-8B27-4055-9A84-6BE6AF6753C2Q35374753-DCEC8D7D-B0A5-4DEF-8408-EA03926F4B18Q35623903-D4A75D47-8A9E-43AA-9147-540C882CE068Q35964621-1B026AD8-2C42-4A95-B244-66AE99675783Q36358324-99D9A8F2-8E5E-4880-85A4-4ED16FFC16A9Q36569018-87097BFC-2B56-4A35-B566-38827DBD49A9Q36842192-B1FA8D6B-0067-4AAD-B782-22E01ECA0415Q37186494-8E9751C7-39BD-4A33-BC13-B1FC64EB5B2CQ37196532-23DBE195-958E-4D8F-B275-5D0ADA26C21CQ37287156-DFBDD73B-4ECC-4DD1-95CD-172F0B656E1CQ37705457-CE7D8219-1293-462F-9BFE-B4CBBFD0B9A1Q37713683-590930E9-22F9-47BF-A40A-F03DEC08C1D1Q37809463-D79BE1C9-0E93-48B9-A3F1-D219872252B2Q39430345-5EAF605B-7B95-48C7-A19C-783D91F85FB2Q40367465-14061EFF-7260-475E-A4F7-C9DB7C230CBFQ45813459-E18F748B-212A-49F5-81F9-C230AB280E42
P2860
IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
IL-6 production in ovarian car ...... and influences local immunity
@ast
IL-6 production in ovarian car ...... and influences local immunity
@en
type
label
IL-6 production in ovarian car ...... and influences local immunity
@ast
IL-6 production in ovarian car ...... and influences local immunity
@en
prefLabel
IL-6 production in ovarian car ...... and influences local immunity
@ast
IL-6 production in ovarian car ...... and influences local immunity
@en
P2093
P2860
P356
P1476
IL-6 production in ovarian car ...... and influences local immunity
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.1999.0973
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1006843836